SWOT Analysis for RxSight Inc

MACD Crossover Above Signal Line
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Increasing Revenue every Quarter for the past 8 Quarters
MACD crossed above signal line previous end of day
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Stock with Low PE (PE < = 10)

Negative Breakdown First Support (LTP < S1)
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Risky Value (DVM)
Low durability companies
Highest fall from 52 Week High
Top Losers
Near 52 Week Low
Negative Breakdown First Support (LTP < S1)
Low Piotroski Score : Companies with weak financials
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter